REMDA Trademark

Trademark Overview

On Tuesday, December 20, 2011, a trademark application was filed for REMDA with the United States Patent and Trademark Office. The USPTO has given the REMDA trademark a serial number of 85500139. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 17, 2015. This trademark is owned by Glaxo Group Limited. The REMDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
remda

General Information

Serial Number85500139
Word MarkREMDA
Filing DateTuesday, December 20, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 17, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "REMDA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 3, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, August 17, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 17, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 9, 2014EXTENSION 5 GRANTED
Tuesday, December 2, 2014EXTENSION 5 FILED
Tuesday, December 2, 2014TEAS EXTENSION RECEIVED
Friday, June 27, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 26, 2014EXTENSION 4 GRANTED
Monday, June 23, 2014EXTENSION 4 FILED
Monday, June 23, 2014TEAS EXTENSION RECEIVED
Friday, January 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 16, 2014EXTENSION 3 GRANTED
Thursday, January 9, 2014EXTENSION 3 FILED
Thursday, January 9, 2014TEAS EXTENSION RECEIVED
Tuesday, August 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2013EXTENSION 2 GRANTED
Friday, July 5, 2013EXTENSION 2 FILED
Friday, August 2, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 5, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 14, 2012EXTENSION 1 GRANTED
Friday, December 14, 2012EXTENSION 1 FILED
Friday, December 14, 2012TEAS EXTENSION RECEIVED
Tuesday, July 17, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 22, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 17, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 17, 2012ASSIGNED TO LIE
Tuesday, March 27, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 20, 2012ASSIGNED TO EXAMINER
Tuesday, January 3, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 23, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

remda pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological